Rybakowski J
Kliniki Psychiatrii Dorosłych AM w Poznaniu.
Psychiatr Pol. 1997 Sep-Oct;31(5):513-26.
In this paper, a progress in research on etiopathogenesis of schizophrenia made in the recent decade was presented. Two main etiopathogenetic factors in this illness include genetic predisposition and brain damage in early period of life, leading to a disorder of brain development and lateralization, and to an increased susceptibility to stress. The use of new methods of genetic studies brought about a significant progress as to identification of relationship between schizophrenia and various changes within genotype. In the 1990s, many data have been obtained concerning possible brain damaging factors as well as the existence of structural and functional brain abnormalities in this illness. Impaired brain development in schizophrenia results in disturbances of neuronal connection in the cortical structures and in cortical-limbic transmission, what may underlie the appearance of psychopathological symptoms. New neuroleptic drugs introduced in the recent years show more complete therapeutic action against schizophrenic symptoms compared with drugs used so far. This may result from their broader influence on the pathogenetic processes of schizophrenia, which may be due, apart from their effect on dopaminergic system, also to their action on some elements of serotonergic neurotransmission.
本文介绍了近十年来精神分裂症病因学研究的进展。该疾病的两个主要病因学因素包括遗传易感性和生命早期的脑损伤,导致大脑发育和功能偏侧化紊乱,并增加对应激的易感性。遗传研究新方法的应用在确定精神分裂症与基因型内各种变化之间的关系方面取得了重大进展。在20世纪90年代,已经获得了许多关于可能的脑损伤因素以及该疾病中脑结构和功能异常存在的数据。精神分裂症中大脑发育受损导致皮质结构中神经元连接和皮质-边缘系统传递紊乱,这可能是精神病理症状出现的基础。近年来引入的新型抗精神病药物与迄今使用的药物相比,对精神分裂症症状显示出更全面的治疗作用。这可能是由于它们对精神分裂症发病机制过程有更广泛的影响,这除了它们对多巴胺能系统的作用外,还可能归因于它们对5-羟色胺能神经传递某些成分的作用。